Tocagen Inc. (TOCA) PT Lowered to $10 at Chardan Capital Markets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Tocagen Inc. (TOCA) PT Lowered to $10 at Chardan Capital Markets

Tocagen Inc. (TOCA) PT Lowered to $16 at Ladenburg Thalmann

May 22, 2019 6:37 AM EDT

Ladenburg Thalmann analyst Wangzhi Li lowered the price target on Tocagen Inc. (NASDAQ: TOCA) to $16.00 (from $20.00) while maintaining a Buy rating.

... More

Tocagen Inc. (TOCA) PT Lowered to $5 at SVB Leerink

May 22, 2019 6:14 AM EDT

SVB Leerink analyst Daina Graybosch lowered the price target on Tocagen Inc. (NASDAQ: TOCA) to $5.00 (from $11.00) while maintaining a Market Perform rating.

... More

Tocagen (TOCA) Says Toca 5 Pivotal Phase 3 Clinical Trial in Patients with Recurrent Brain Cancer Continues Without Modification at Planned Interim Analysis

May 21, 2019 4:10 PM EDT

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the Toca 5 Phase 3 clinical trial evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma (HGG) continues without modification following a planned interim analysis of data conducted by an Independent Data Monitoring Committee (IDMC). The... More